GNH USA

Europe — EMA

Nefrosol Kálium

GNH USA supplies Nefrosol Kálium (electrolyte solution), a fluid and electrolyte replacement drug for electrolyte replacement, acid‑base balance correction

Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc

Request sourcing

1
Pack/s

What is Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc?

Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride and Calcium (Calc), the active ingredients in Nefrosol Kálium, are an electrolyte solution presented as an intravenous solution for fluid and electrolyte replacement use. It corrects electrolyte imbalances and acid‑base disturbances in patients requiring intravenous therapy and is manufactured for the EU market.

GNH USA supplies Nefrosol Kálium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

What is Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc used for?

Nefrosol Kálium is an intravenous electrolyte solution used in clinical situations that involve fluid loss or electrolyte disturbance.

- Electrolyte replacement: restores sodium, potassium, magnesium and chloride concentrations in patients with depletion. - Acid‑base balance correction: provides bicarbonate ions to correct metabolic acidosis. - Fluid resuscitation: delivers isotonic fluid volume to support circulation in hypovolemic states.

What are the side effects of Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc?

Adverse reactions may occur with any intravenous electrolyte preparation. Monitoring and prompt management are essential.

Common Side Effects: - Mild hypernatremia: elevated serum sodium levels. - Transient hyperkalemia: temporary increase in potassium. - Local irritation: pain or erythema at the infusion site. - Hypocalcemia: reduced calcium levels if calcium content is low. - Metabolic alkalosis: over‑correction of acidosis.

Serious or Rare Side Effects: - Severe hyperkalemia: cardiac arrhythmia risk. - Hypermagnesemia: neuromuscular depression. - Fluid overload: pulmonary edema. - Severe electrolyte imbalance: neurologic symptoms. - Anaphylactoid reaction: hypotension and bronchospasm.

What precautions apply to Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc?

Use Nefrosol Kálium only under medical supervision with appropriate laboratory monitoring.

- Assess baseline electrolytes: obtain serum sodium, potassium, magnesium, chloride and bicarbonate before infusion. - Adjust infusion rate: tailor speed to patient volume status and cardiac function. - Monitor cardiac rhythm: especially in patients with renal impairment or existing electrolyte abnormalities. - Avoid rapid correction: prevent osmotic demyelination or sudden shifts in acid‑base balance. - Contraindications: do not use in patients with known hypersensitivity to any component. - Store at ambient temperature: keep in original container, protect from light and moisture.

What does Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc interact with?

Electrolyte solutions can interact with other medicines that affect ion balance or renal function.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may potentiate hyperkalemia. - Digoxin: increased risk of toxicity with elevated potassium. - Loop diuretics: can cause rapid shifts in sodium and potassium.

Moderate Interactions (Monitor Closely): - NSAIDs: may impair renal clearance of electrolytes. - Lithium: altered lithium levels with sodium changes. - Antacids containing aluminum or magnesium: additive electrolyte load.

Frequently asked questions

What is Nefrosol Kálium used for?+
Nefrosol Kálium is an intravenous electrolyte solution used to replace lost sodium, potassium, magnesium and chloride, to correct metabolic acidosis, and to provide fluid volume in patients who need resuscitation or maintenance of electrolyte balance.
How does the active ingredient work in Nefrosol Kálium?+
The formulation delivers sodium, potassium, magnesium, chloride and bicarbonate ions directly into the bloodstream, replenishing extracellular electrolyte pools, supporting nerve and muscle function, and buffering excess hydrogen ions to restore normal acid‑base status.
What is the usual dose of Nefrosol Kálium?+
The dose of Nefrosol Kálium is determined by the prescribing clinician based on the patient’s electrolyte levels, fluid status, weight and clinical condition. No fixed regimen is provided here.
Is Nefrosol Kálium safe during pregnancy or breastfeeding?+
Safety data for Nefrosol Kálium in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and under close medical supervision.
How do I order Nefrosol Kálium from GNH USA?+
Submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Nefrosol Kálium compare with other electrolyte solutions?+
Nefrosol Kálium contains a balanced mix of sodium, potassium, magnesium, chloride and bicarbonate, offering both electrolyte replacement and acid‑base correction in a single IV bag. Some alternatives may lack bicarbonate or magnesium, requiring additional agents for complete correction.
What are the storage and handling requirements for Nefrosol Kálium?+
Store at ambient temperature, below 25 °C, in the original packaging. Protect from direct sunlight, moisture and extreme temperatures to maintain solution stability.
How is Nefrosol Kálium administered?+
Nefrosol Kálium is administered intravenously. The infusion rate is set by the healthcare professional according to the patient’s clinical needs, usually through a calibrated infusion pump or gravity drip.
What are the most serious risks associated with Nefrosol Kálium?+
Serious risks include severe hyperkalemia leading to cardiac arrhythmias, fluid overload causing pulmonary edema, and rapid over‑correction of acid‑base status resulting in metabolic alkalosis. Continuous monitoring is essential.
Who should not receive Nefrosol Kálium?+
Patients with known hypersensitivity to any component, those with uncontrolled hyperkalemia, severe renal failure without appropriate monitoring, or individuals for whom rapid electrolyte shifts are contraindicated should not receive this product.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc
Route
Intravenous Use
Manufacturer
B.Braun Avitum Ag
Origin
EU